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The purpose of this presentation is twofold: (1) 
to describe a concept of biologic regulation in 
wh ich two cellular components, cyclic GMP and 
cycl ic AMP, are envisioned to provide the facili-
tory and suppressive ini1uences that conirol a va-
rielY of biologic events; and (21 to iniroduce the 
concept that the intracellular availabil ity of spe-
cific cations may sele("\i\'el~' regulale cydic nucleo-
tide participation in modulating cell ular e\·ents. 
RE ClPRO C" AL CO:\TROL OF BIDIREC"TlO:\ALLY 
HEGlIL.HEO I';\,E:\TS BY CYCLIC C MP A:\ O CYCLIC 
A,1P: THE YI:\ YA:--;C; HYPOTHESI>; OF HIOLOGI C" 
C() :\TROL 
From the pioneering work of Sutherland and his 
co-workers. it is now generally understood that 
cyclic AMP can serve as the intracellular effector 
of a variety of cellular events [J I. It is now 
becom ing apparent that another naturally occur-
ring cyclic nucleotide, cyclic GMP. may also be of 
considerable importance as a regulatory effector. 
Experiments focused on elucidating the biologic 
importance of cyclic GMP have led to a series of 
discove ries that link cyclic GMP to the actions 
produ ced by a variety of agents thai p romote 
cellular events opposite to those believed to be 
promoted by cyclic AMP. From these observations 
a new concept of regulation has been proposed 
whereby the two cyclic nucleotides , cyclic AMP 
and cyclic GMP. are envisaged to impose opposing 
influences in a number of systems 12- 4] . The 
concept has been t.ermed the Yin Yang H ypothesis 
of Biological Control because in Oriental cultures 
this term symbolizes a dualism between opposing 
natural forces which may. under certain circum-
stances. enter into a mutual interaction tha I re-
sults in a s~'nthesis. The latter silLlat ion ma~' char-
acterize certa in biologic processes comprised of a 
series of regula ted steps. 
Before developing details of the hypothesis, it 
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may be well to emphasize that the complexities 
that characterize the great variety of cellular 
processes susceptible to regulation are well appre-
ciated. However, biologic regulation, in very basic 
terms. can he viewed as a process of imposing 
positive and negative controlling influences on 
cellular events. It would seem appropriate, there-
fore. to begin with a relatively simple model from 
which to develop a more complete understanding 
of the complexities that are involved . 
In its simplest form. our hypothesis defines 
cyclic GMP and cyclic AMP ag key biologic 
effectors involved in regulating cellular functions 
which could be considered to be controlled bidirec-
tionally. A bidirectionally regulated cellular proc-
ess is considered to be one which is in a functional 
state and susceptible to both stimulatory and 
inhibitory controlling influences. Such a process 
may involve a single pathway or opposing unidirec-
tional pathways which are affected reciprocally. 
We have postulated that there are two basic types 
of simple bidirectionally controlled systems: A-
type systems which are facilitated by cyclic AMP 
and suppressed by cyclic GMP. and B-type sys-
tems which are promoted by c~'c1ic GMP and 
inhibited by cyclic AMP. The influence of either 
cyclic nucleotide may be imposed by an elevation 
of its cellular concentrat ion or by a change in the 
composition of the cellular milieu which would 
allow one or the other to act effectivel~·. This idea 
takes into account a change in the ratio of the two 
effectors as well as a possible change in a specific 
cell constituent such as a cation that mav be 
requ ired for the functional participation of the 
particular cyclic nucleotide. The hypothesis does 
not require that reciprocal changes t.ake place in 
the cellular concentrations of t he two cyclic nudeo-
tides. This may occur. however. when a system is 
under the prior influence of an opposing signal, and 
lowering the level of the antagonistic cyclic nucleo-
tide effector to a basal level (from the prestimu-
lated le\'eli would be required for 1 he full expres-
sion of the newly arriving signal. An example of a 
sim pIe bidirectionally controlled system of the A 
type may be cardiac contractility, while smooth 
muscle contract ion would be considered to be an 
example of the B type . 
In contrast to these relatively "simple" regu-
lated systems there a re the more complex biologic 
processes that. may be comprised of a series of 
individual cellular events (i.e., the proliferative 
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process; hormone biosynthesis, storage, and secre-
tion; etc.). Each of the individual steps comprising 
these overall processes may be susceptible to 
regulatory influences imposed through the two 
cycl ic nucleotides. For certain of the processes. 
t he individual sequential steps may be dependent 
on the progression of the preceeding step. and in-
fluences b~' one or the other effector in sequential 
fashion may be required to promote the overall 
process. A suppressive influence by one cyclic 
nucleotide effec tor on an individual step in the 
sequence may prevent the process from proceeding 
to completion. Al though several steps in the 
sequence may be affected rec iprocally by the two 
cyclic nucleotides. there may also be a specific step 
that is stimulated by both effectors (i .e. , a ., mono-
directionally" regu lat.ed step [4]). An example of a 
system in which such a step could occur is a 
synthesis-secretion system where t he biosynthesis 
of product is needed to meet two different require-
ments: to satisfy the current demand of the stimu-
lated state or to replenish depleted stores of 
secretory product. The foregoing is still a matter of 
conjecture but is meant to underscore the impor-
tance of thoroughly defin ing t.he biologic system 
under investigation in terms of the individual step 
that may be im·olved. the various sites at which 
regulation may be imposed. and the different 
circumstances that may arise and call fo r a partic-
ular combination of controlling influences. 
Although it is proposed that this general model 
involving the two cyclic nucleotides may apply t.o 
most forms of hormonal regulation and to other 
biologic signals, it does not exclude the existence of 
alternative mechanisms for affecting cellular func-
tion. 
The evidence in support of the concept we ha\'e 
proposed derives from t.wo lines of investigation. 
The fi rst has shown t ha t anum ber of biologically 
active agents that cause the accumulation of 
cellular cyclic GMP also promote cellular events 
opposite to those elicited by agents that stimulate 
cell ular AMP accumulation. The second has shown 
that exposure of cells to cyclic GMP (or appropri-
ate derivatives) can cause cellular alterations that 
are the reciprocal of those that occur upon expo-
sure to cycl ic AMP (or appropriate derivatives!. 
The fi rst line of investigation had its beginning 
when it was observed that acet~'lcho l ine-induced 
suppression of cardiac contractility occurred in 
association with a rapid increase in the ti ssue 
concentration of cyclic GMP [5]. Considering that 
epinephrine-induced stim ulation of heart function 
occurs in association with a rapid accumulation of 
cellular cyclic AMP, it was apparent that the two 
cyclic nucleotides might be involved in promoting 
opposing regulatory influences in this tissue and 
that some aspect of acetylcholine action in cardiac 
muscle might be expressed through some intracel-
lular influence of cycl ic GM P . Isoproterenol-
induced stimulation of contract ion was also shown 
to diminish the levels of cyclic GMP by about 50% 
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[5]. Acetylcholine can now be shown in a variety of 
different t issues to promote cellular cyclic GMP 
accumulation [6 ] and in each of the tissues or cell" 
in which the inf1.uence of acetylcholine on cell 
function is definable (and of the muscarinic type) 
the effect produced by th is neurohormone is oppo· 
site to that produced by agents (i.e., ~-adrenerg i csl 
that elevate cellular cycl ic AMP concentration. In 
addition to acetylcholine, a number of other agent ' 
and conditions t ha t promote so-called "cycli{ 
AMP antagonistic" events in highly diffe rentiated 
cells have been shown to do so in association wit h 
an elevation of cellu la r cyclic GMP concentratio" 
16 J. This list now includes hormonal and neurohor 
monal agents such as prostagla ndin F 2,,, serotoni n 
oxytocin, a-adrenergics, insulin , cholescystokinin. 
somatostatin. and nonhormonal agents such a-
phorbol myr istate acetate, serum-coated zymosan 
particles (which promote lysosomal enzym e 
release l. and the ionophore-A23187 which appears 
to promote a variety of calcium-dependent proc-
esses. The list of agents now shown t.o promote 
cyclic GMP accumulation is as d iverse as the list of 
cellular processes tha t are affected. However, t he 
com monality exists in the nature of the cellular 
responses, all of whic h are opposite to those that 
occur in response to agents that stimulate the 
cellular accumu lation of cyclic AMP. 
Although the unequivocal proof establishing 
cyclic GMP or cyclic AMP as the mediators of 
opposing influences in various systems is still 
forthcom ing, the continuing effort to test the 
hypothesis has produ ced new information that 
helps to extend our understanding of how cyclic 
nucleotides and other cell constituents may be 
interrelated. An illustration of the latter is the 
recent observat ion t hat cyclic GMP metabolism 
can be markedly affected by ascorbic ac id . 
ASCORBIC' AC'ID 
During the course of experiments in which the 
role of cyclic GMP was under investigation a a 
modulator of platelet function . it was found that 
ascorbic acid, which was employed as an antioxi· 
dant in solutions of epinephrine used to induce 
plate let aggregation, promoted 180-fold increases 
in pl atelet cyclic GMP concentration within 5 sec 
after exposure [6]. This effect of ascorbic acid is 
selective with regard to cyclic GMP since there was 
no significant change in cyclic AMP levels under 
these conditions. The increase in platelet cyclic 
GMP concentra tion which appears to be attributa· 
ble to ascorbic acid is not induced by equimolar 
concentration of everal reducing agents which 
have been tested , including dithiothreitol, glut.a-
thione, sodium metabisulfite , a nd mercaptoetha· 
n ol, or by a number of other weak acids which have 
been examined. T he ability of ascorbic ac id to 
promote an accumulation of cyclic GMP certainh 
provokes a new interest in effects that t his vitam in 
may have on cyclic nucleotide metabolism in th i, 
and other systems. 
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Since the ascorbic acid-induced increase In 
platelet cyclic GMP does not by itself lead to 
aggregation, the role played in this process by 
cyclic GMP remains to be established . S ince it is 
now known that various aggregating agents (i.e., 
prostaglandin endoperoxides, collagen) elevate 
cycl ic GMP levels shortly (J min) after in itiation of 
platelet aggregation (D. Glass. J. Gerrard. D . 
Towsen d. J. White, and N. Goldberg, ullpublished 
data) , cyclic GMP may not be involved in the first 
stage of reversible aggregal ion but it may be in -
volved in the processes leading to irreversible ag-
gregation. 
CELL PROLIfEHATIO;-': 
In addition to the effects that cyclic nucleotides 
may have on the function of so-called "differenti-
ated " cells. there is evidence that cyclic AMP and 
cyclic GMP may play major regulatory roles in the 
proliferative and differentiative processes . It has 
been shown in a number of laboratories [7.8] that 
elevated le"els of cellu lar cyclic AMP inhihit pro-
liferation and promote differentiation . Although it 
has been proposed that a lowering of cellula r cyclic 
AMP concentrat ion may represent a state that 
perm its proliferation to occur. it has now been 
shown in a number of case. tha t condi tions wh ich 
st imula te cell proliferation do ~o in assoc iation 
with elevat ions of cellular c,vclic GMP concentra-
tion 14]. The possibi lity that c~' cli c GMP might 
represent an intracellular mediator of the prolifera-
tive process was fi rst suggested on the basis of the 
observation that mitogenic concentrations of phy-
tohemagglutin in (PHA ) or cancanavalin A 
(Con-A ) produced great.er than lO-fold increases in 
t he cyclic GMP levels of human peripheral blood 
lymphocytes within 10 min with li ttle or no change 
in the levels of c~' clic AMP [9]. Since t hen it has 
been shown that several agents which promote 
prolifera tion in different ce ll types produce simi-
larly striking increases in cyclic GMP concentra-
tions [6]. In fibrob lasts. for example. insulin. fresh 
serum , fibrob last growth facto r, and phorbol 
myristate acetate have been shown to produce 
marked elevations of cyclic GMP within just 
seconds or minutes. In mouse epithelium. phorbol 
myristate acetate and histami ne. which stimulate 
these cells to divide. elevate t he levels of cyclic 
GMP. The meristematic (proliferative) regions of 
pea and bea n seedl ing roots and stems contain 
much higher concentrations of cyclic GMP (by as 
much as 70-fold ) than the non proli fe rat ing, elon-
gating cells. From the time course of the changes of 
cyclic GMP following addition of various mitogens 
such as serum, insulin , or fibroblast growth factor. 
it appears that the in crease in cyclic G MP occurs 
only during a specific period of time in the earl." G l 
phase of t he cell cycle and that this may represent 
an important signal for initiating the progression of 
~vents involved in cell proliferation. 
Even in some malignant cells which generally 
~xhibit low basal levels of cyclic GMP in asynchro-
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nous cul tures. synchronizat ion reveals the ex ist-
ence of t ransient i.ncreases in cyclic GMP during 
G, [6]. 
ESTROGE~ 
After the relationship between cell proliferation 
and cyclic GMP was established with mitogenic 
agents which were t hought to act a t the level of the 
plasma membrane, one of the questions that arose 
was whether mitogenic agents such as steroids 
which a re thought to act int.racellularly also pro-
moted cellular cyclic GMP accumulation . Estro-
gen, which promotes cell proliferation of uterine 
endometrium. was examined in th is regard 110J. It 
was found that estradiol- 17/3 or diethylstilbestrol 
[10] promoted striking increases of 7- t.o to-fo ld in 
uterine cyclic GMP while a t t he same time the 
concentration of cyclic AMP was lowered (a pproxi-
mately 50~ ) in this tissue. 
There is a t ime-dependent lag of 60 to 90 min 
before the rise of cyclic GMP occurs and the rise is 
blocked by puromycin, cycloheximide. and high 
concentration of actinomycin D. These experi-
ments suggest that a protein is induced which 
m ight functi on to enhance cyclic GMP generation. 
retard its degradation by inhibiting phosphodies-
terase. or prevent its degradation by complexing 
with it. The possibility that a protein inducible by 
estrogen is im'olved in bringin~ about the accumu-
lation of tissue cyclic GMP (and /or lowering of 
cyclic AMP levels) is of considerable interest since 
it could represent a component sim il ar or ident ica l 
to t he fo rmerly described estrogen "i.nduced pro-
tein" (lPI [11]. 
OPPOSI~(; EFFECTS OF E:\OGE~Ol'S ('YC Ll e C:v!p 
Al\D CYCLlC Al'v! P 
One of the problems that is still not completely 
resolved and continues to impede progress in 
establishing the precise biologic role of cycli c GMP 
is the fact that exposure of intact cells to this cyclic 
nucleotide often produces no effect or t he same 
effect as exogenously added cyclic AMP. It has 
been suggested [3] t ha t excessively high concent ra-
tions of exogenous cyclic GMP (i .e., millimolar 
range) interact nonspecifically with components 
more selective for cyclic AMP, resulting in an 
effect similar to that obtained with cyclic AMP. 
However. addition of cyclic GMP (or the 8-bromo 
or d ibutryl derivatives ) in the micromolar or sub-
micromolar concentration range often induces 
effects on cell functions that are opposite to those 
promoted by the addition of any concentration of 
cyclic AMP. An example of an intact cell system in 
which opposing effects of the two cycl ic nucleotides 
can be demonstrated is tbe chemotactic respon-
siveness of polymorphonuclear leukocytes (PMN ) 
[1 2.13]. With the PMN it can be shown that 
agents , such as /3-adrenergic catecholamine:; or 
PGE , (which elevate cyclic AMP levels in the cells) 
or exogenous cyclic AMP. inhibit motilit.y induced 
by bacteria l chemotactic facto r. On the other 
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hand, a -adrenergic agents, acetylcholine, low con-
centrations (10 - ' and 10- 7 M) of PGF , .. (which can 
be shown to elevate cyclic GMP levels in the 
PMN ), or exogenous cyclic GMP in the concentra-
tion range of 10- 9 to 10 - 7 M enhan ce chemotaxis 2-
to 3-fold . The peak effect is achieved at 10 - . M 
cyclic GMP. Concentrations of cyclic GMP be-
tween 10- 6 to 10- 5 M are without effect, and at 
10- ' M an inhibitory effect l ike that produced by 
cyclic AMP is obtained. 
Opposing effects of the two cyclic nucleotides (or 
appropr iate derivatives ) have also now been dem-
onstrated on short-circuit current generation in 
frog skin (unpublished observations), histamine 
release from mast cells [14], lysosomal enz~'me 
release from leukocytes [15.16]. sheep red blood 
cell binding to mouse lymphocytes [17 ], transport 
of se\-eral substances b~' fibroblasts [18]. the polar-
ization of postsynaptic membranes in superior 
cervical ganglia [191. the rate of neuronal firing in 
somatosensory cells of t.he cortex [20], the cytotox-
icity of lymphocytes [21], and the rate of cardiac 
muscle cell contraction [22]. With the greate r 
appreciation for what appears to be a more subtle 
concentration dependence of effects elicited by 
cyclic GMP (bell-shaped rather than sigmoidal 
concentration-response curves) and a more di-
rected intuition as to the effect that it may produce 
with respect to cyclic AMP. it can he predicted 
that a number of other systems will be shown to 
respond reciprocally upon exposure to the two 
cyclic nucJeotides . 
CATIO:\ ·I:\OlT ED \lODl 'LATIO" OF rYC LIC 
!\LTLEOTIDE I)lTERACTIO:\S WITH CELLt 'LAR 
rO:vfPO:\E:\T" 
Skeletal Mus cle Cy clic AMP-Dependent Protein 
Kinase 
A variety of hormonal agent can be demon-
strated to promote increases in the cellular con-
centrat ion of cyclic A:v1P (or cyclic GMP) and this 
fact has been e xtremel~' useful in implicating cyc-
lic nucleotides as cellular mediators of hormonal 
actions. Th is relat ionship between hormone and 
cvcl ic nucleotide concentration served as an im-
p-~rtant criterion for the de\"elopment of Suther-
land's " second messenger hypothesis." Howe\·er. 
there is evidence accumulating which indicates 
that alterations occur in the levels of certain cell 
constituents that may modulate the interaction 
of a cyclic nucleotide with a specific cellular com-
ponent. In this case a cyclic nucleotide could be 
envisaged to influence a cellular event without any 
immediate change occurring in its cellular concen-
tration. 
Consistent with this concept is the observation 
that ATP (Mg h ) can inhibit cyclic AMP binding 
to a major species of skeletal muscle protei n ki-
nase [4]. The inhib itory effect requires both the 
t riphosphate and Mg'- ; neither alone is effective. 
The inhibi tory effect of ATP (Mg'- ) results in a 
lO-fold [23 ] to 50-fold [24] increase in the requi re-
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ment for cyclic AMP in both the protein kinase 
complexing reaction and the activat.ion of phospho-
transfe rase activity [25 ]. The inhibition of cyclic 
AMP reactivity was found to be reciprocally re-
lated to the binding of [' H ]A TP to the protein 
kinase and the apparent Kd value ATP binding wa> 
approximately 10 - 7 M . The binding of ATP 
(Mg 2+) to the protein kinase and the inhibitofl' 
influence imposed as a result did not lead to an~' 
detectable t ransformation of the ATP [23]. Th·[· 
high affini ty site of STP (Mg 2+) in add ition to th ,· 
catalytic subunit was required for the release I ' 
bound cyclic AMP from the regu latory subun it 
[251· 
The physio logic significance of these observa 
tions is not yet understood, but since the ATP 
requirement for this effect (10- ' M range) is severa l 
logs lower than the levels of ATP (10 - 3 M range). it 
is conceivable that the cation might. serve as the 
allosteric determinant. This possibility was exam -
ined by t.esting cations other than magnesium for 
their ability to support ['H ]ATP binding to protein 
kinase and t.o suppress reactivity of the kinase with 
cyclic AMP. Mn' + and Ca'- were both found to be 
as effective as Mg' - in promoting ATP binding to 
the kinase but unlike ATP (Mg2+) or ATP (Mn H I. 
ATP (Ca'~l. when in complex with the enzyme, 
did not inhibit cyclic AMP binding. Variations in 
the availability of free intracellular calcium migh t 
allow for an exchange of calcium for magesium 
complexed with the protein kinase (by ac t ive or 
passive mechanism ). Such an exchange would 
result in a decrease (1 / 10 to 1/50) in the requ ire-
ment of the protein kinase for cyclic AMP. The 
tissue concent ration of cyclic AMP which rna \" 
have been inadequate t.o stimulate the kinase whe~ 
it was complexed with magnesium could now 
become effective . [fsu ch a mechanism is opera tive. 
it would represent an alternative means for pro-
moting an event through an influence of a cyclic 
nucleotide without the concentration of this com-
ponent necessarily increasing in t he cell. 
Cation-Dependent Cy clic GM P Binding Protein 
One feature of many cellu lar events , promoted 
by agents which have been shown to stimula te 
cyclic GMP accumulation, is an apparent require-
ment fo r di\'alent cation, namely calcium [26.:"l[. 
When approaching the problems of identifying the 
cellular component(s) with which cyclic GMP may 
in teract to influence certain ce llular events. it 
would seem reasonable to expect that. interaction 
of t his cyclic nucleotide with specific cell ular 
components would exhibit a dependence upon 
divalent cation. It was with this view of the 
problem that investigations were conducted to 
uncover a cellular component with which cycl i( 
GMP might specifically interact. 
Preliminary experiments along t hese line wert 
conducted by determining what influence Ca H 0 
MgH might have on the formation of protei. 
complexes between cyclic GMP and soluble cell t 
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lar components contained in a 40,000 x g superna-
tant fraction of uterine homogenates that con-
tained EDTA (5 mM) and the phosphodiesterase 
inhibitor MIX (l-methyl-3-isobutylxanthine) (2 
mM). It was found that each of the cations pro-
moted a significant enhancement (greater than 
100<), ) of [3H ]cyclic GMP binding as determined 
by the retention of complexes on Millipore filters. 
Under similar conditions [3H Jcyclic AMP binding 
was affected only sl ightly but in an opposite man-
ner (i.e .. diminished l6 to 25'1i ). 
In subsequent experiments it was possible to 
demonstrate the occurrence of cellular constituents 
in uterine tissue separable by sucrose density 
gradients that bind cyclic GMP rather selectively 
with an apparent dependence on Ca'~ for the 
interaction. However. only when the homogenate 
was exposed to ['Hjcyclic GMP and Ca H before 
centrifugation could appreciable binding to a low-
molecular-weight component be domonstrated. 
Furthermore, the addition of ethylene glycol tet-
raacetic acid IEGTA) (5 mM) to the density 
gradient-separated cyclic GMP binding fract ion 
obtained after centrifugation in the presence of 
Ca'· and [3H jcyclic GMP did not promote release 
of the labeled cyclic nucleotide. This suggests that 
calcium probably does not bind to the same 
subunit that complexes with the cyclic nucleotide 
or that. once bound together with cyclic GMP. the 
calcium is not removed by EGTA. Experiments 
conducted to det.ermine the distribution of bound 
"Ca" under similar conditions. tentatively elimi-
nated the latter possibility. The binding of cyclic 
GMP to this component was specific in thaI 
lOO-fold excess concentrations of cyclic AMP and 
5'-GMP did not in terfere with cyclic GMP binding. 
When examining the cation specificity for 
[3H ]cyclic GMP binding it was found that Mn '-
enhanced c~'clic GMP binding to two components. 
one of which was very different from the major 
peak that emerges in the presence of Ca , . and 
another t hat migrates in close proximity to the 
[3H /cyclic GMP binding peak obtained in the 
presence of Ca h Experiments conducted to iden-
tify the "calcium dependent" cyclic GMP binding 
peak indicate that it has a molecular weight of 
approximately 23.000 and that it exhibits no phos-
photransferase or phosphoprotein phosphatase ac-
tivity. The possibility that it may modify act ivi ties 
of either of the latter enzymes has not been entirely 
eliminated. 
Although the identity of the cyclic GMP binding 
proteins demonstrable under t.he conditions de-
scribed remains to be determined , one interesting 
characteristic the~' seem to exhibit is a dependence 
upon specific cations for interaction with cyclic 
GMP. These observations are con istent with the 
concept that cyclic nucleotide parti ci pation in the 
process of biologic regulation may be modulated by 
cytoplasmic cations and they raise the possibility 
that a change in the intracellular level of either 
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cyclic nucleotide or of appropriate cation may 
serve to promote the participation of both as 
regulatory effectors. 
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